Skip to main content
PMC home page
Springer logoLink to Springer
. 2023 Dec 9;28(2):123–124. doi: 10.1007/s10157-023-02436-9

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Motoko Yanagita 1,2,✉, Satoru Muto 3, Hiroyuki Nishiyama 4, Yuichi Ando 5, Sumio Hirata 6, Kent Doi 7, Yutaka Fujiwara 8, Norio Hanafusa 9, Takahiro Hatta 10, Junichi Hoshino 11, Satoko Ichioka 12, Takamitsu Inoue 13, Kenji Ishikura 14, Taigo Kato 15, Hiroshi Kitamura 16, Yusuke Kobayashi 17, Yuichi Koizumi 18, Chihiro Kondoh 19, Takeshi Matsubara 1, Kazuo Matsubara 20, Koji Matsumoto 21, Yusuke Okuda 14, Yuta Okumura 22, Emiko Sakaida 23, Yugo Shibagaki 24, Hideki Shimodaira 25, Nao Takano 26, Akiko Uchida 27, Kimikazu Yakushijin 28, Takehito Yamamoto 29, Kazuhiro Yamamoto 30, Yoshinari Yasuda 31, Mototsugu Oya 32, Hirokazu Okada 33, Masaomi Nangaku 34, Naoki Kashihara 35
PMCID: PMC10808267  PMID: 38070021

Correction to: Clinical and Experimental Nephrology 10.1007/s10157-023-02415-0

In the original publication, the abstract text has been inadvertently included in the article. We have removed the abstract text in the updated version.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Clinical and Experimental Nephrology are provided here courtesy of Springer

RESOURCES